Protembis GmbH

Protembis GmbH

Protembis GmbH

ProtEmbo Deflects Embolic Material Away from the Brain During TAVR ProtEmbo is the bestinclass system providing a simple, quick, reliable solution to reduce the risk of cerebrovascular events during transcatheter aortic valve replacement (TAVR).
Raised
$10M
Follow us
Alexa global traffic share
Latest funding
$10,000,000
Venture capital (Series A) - 2018
Coparion Abiomed Seed Fonds III +1
Team Size
1–10
Employees
Location
Headquarters
$10,000,000 Venture capital (Series A)
FinSMEs

Protembis Closes $10M Series A Funding

Health Funding